BioCentury
ARTICLE | Clinical News

Indacaterol/glycopyrronium bromide/mometasone fuorate: Phase III started

January 11, 2016 8:00 AM UTC

Vectura and Sosei said Novartis began a double-blind, international Phase III trial to compare 2 dose levels of inhaled QVM149 vs. 2 dose levels of Novartis’ inhaled indacaterol/mometasone furoate ( Q...